Bochum, Germany

Jörg Petersen-von Gehr

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jörg Petersen-von Gehr. Retrieved from https://idiyas.com/inventor/jandoumlrg-petersen-von-gehr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jörg Petersen-von Gehr and His Pharmaceutical Invention.

Introduction

Jörg Petersen-von Gehr is an inventor associated with Bochum, Germany, and Bayer Aktiengesellschaft. His patent work includes an invention concerning expandable pharmaceutical forms.

Latest Patents

Petersen-von Gehr is credited with 1 patent, titled “Expandable Pharmaceutical Forms.” The invention concerns administration forms designed to remain in the stomach for a relatively long time. It uses mixtures of polymers containing lactam groups and polymers containing carboxyl groups, combining pronounced swelling with dimensional stability in the swollen state.

Career Highlights

His recorded patent is associated with Bayer Aktiengesellschaft, a pharmaceutical and life sciences company. The invention addresses the design and performance of pharmaceutical administration forms.

Collaborations

Petersen-von Gehr’s listed coworkers include Gunther Penners and Klemens Lustig.

Conclusion

Jörg Petersen-von Gehr’s patent on expandable pharmaceutical forms reflects work on combining prolonged gastric residence, swelling, and structural stability in drug administration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…